Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.47EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.47NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
ED.1SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-3043.11China
ED.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ED.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BN.1.2.2SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-3043.11China
BN.1.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.2.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
CQ.2SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-3043.11China
CQ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CQ.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
CH.1.1.24SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-3043.11China
CH.1.1.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.24NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BA.5.2.43SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
BA.5.2.43EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.43NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BA.5.2.19SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
BA.5.2.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.19NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BF.38.3SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
BF.38.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.38.3NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-18896.7US
BF.7.19.1SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
BF.7.19.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.19.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BQ.1.1.43SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
BQ.1.1.43EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.43NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BA.5.2.12SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
BA.5.2.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.12NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BF.7.23SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
BF.7.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.23NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
B.1.1.214SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
B.1.1.214EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.214NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
B.1.1.284SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
B.1.1.284EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.284NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
B.1.351.3 (Beta)SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
B.1.351.3 (Beta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.351.3 (Beta)NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
B.1.1.318SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
B.1.1.318EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.318NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
R.1SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
R.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
R.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used